Conduit Pharmaceuticals Inc (NASDAQ: CDT) is -99.80% lower on its value in year-to-date trading and has touched a low of $2.21 and a high of $1350.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CDT stock was last observed hovering at around $2.8 in the last trading session, with the day’s gains setting it 0.12%.
Currently trading at $2.92, the stock is 15.01% and -35.97% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.16 million and changing 4.29% at the moment leaves the stock -95.94% off its SMA200. CDT registered -97.16% loss for a year compared to 6-month loss of -97.44%. The firm has a 50-day simple moving average (SMA 50) of $4.5607 and a 200-day simple moving average (SMA200) of $71.8735.
The stock witnessed a -9.60% gain in the last 1 month and extending the period to 3 months gives it a -73.94%, and is 16.33% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.52% over the week and 9.35% over the month.
Conduit Pharmaceuticals Inc (CDT) has around 6 employees, a market worth around $2.21M and $0.00M in sales. Distance from 52-week low is 32.13% and -99.78% from its 52-week high. The company has generated returns on investments over the last 12 months (-701.48%).
41.0 institutions hold shares in Conduit Pharmaceuticals Inc (CDT), with institutional investors hold 4.45% of the company’s shares. The shares outstanding are 0.76M, and float is at 0.74M with Short Float at 13.87%. Institutions hold 3.63% of the Float.
The top institutional shareholder in the company is BARCLAYS PLC with over 0.81 million shares valued at $0.86 million. The investor’s holdings represent 0.0015 of the CDT Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 0.69 million shares valued at $0.73 million to account for 0.0012 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 0.41 million shares representing 0.0007 and valued at over $0.43 million, while VANGUARD GROUP INC holds 0.0006 of the shares totaling 0.34 million with a market value of $0.36 million.
Conduit Pharmaceuticals Inc (CDT) Insider Activity
The most recent transaction is an insider sale by Nirland Ltd, the company’s 10% Owner. SEC filings show that Nirland Ltd sold 1,500,000 shares of the company’s common stock on Oct 03 ’24 at a price of $0.10 per share for a total of $0.16 million. Following the sale, the insider now owns 8.4 million shares.
Conduit Pharmaceuticals Inc disclosed in a document filed with the SEC on Oct 04 ’24 that Nirland Ltd (10% Owner) sold a total of 1,368,991 shares of the company’s common stock. The trade occurred on Oct 04 ’24 and was made at $0.10 per share for $0.14 million. Following the transaction, the insider now directly holds 7.03 million shares of the CDT stock.
Still, SEC filings show that on Oct 07 ’24, Nirland Ltd (10% Owner) disposed off 939,009 shares at an average price of $0.10 for $96530.0. The insider now directly holds 6,092,000 shares of Conduit Pharmaceuticals Inc (CDT).
